Ozempic Could Help Curb Alcoholism
By Ernie Mundell HealthDay Reporter
WEDNESDAY, Nov. 13, 2024 -- The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows.
Numerous studies had already hinted that semaglutide might act on appetite centers in the brain to suppress the urge to drink, just as it does the urge to overeat.
Now, researchers in Finland say their nearly nine-year study of almost 228,000 Swedish people with alcohol use disorder who were taking semaglutide had a 36% lower odds of requiring hospitalization.
Use of a second drug in the same class of GLP-1 medications, liraglutide (Victoza), was linked to a 28% reduction in hospitalizations, the team reported Nov. 13 in the journal JAMA Psychiatry.
The study couldn't prove cause and effect, only associations. However, based on these and prior findings, the researchers say that "clinical trials are urgently needed to confirm these findings."
The research was led by Dr. Markku Lähteenvuo, of the University of Eastern Finland.
Besides the finding that both semaglutide and liraglutide appeared to help keep people with alcohol use disorder out of the hospital, the study also found that semaglutide, in particular, was linked to a decreased risk for suicide.
The researchers also noted that the two GLP-1 drugs appeared to outperform standard anti-alcoholism medications, such as naltrexone, disulfiram and acamprostate, in lowering hospitalizations among people with alcohol use disorder, although better studies are needed to confirm that.
The Finnish group noted that better treatments for alcohol use disorder are desperately needed, "because existing treatments may not be suitable for all patients."
Sources
- JAMA Psychiatry, Nov. 13, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Diet, Exercise Protect Liver Health From Alcohol Damage, Study Says
THURSDAY, Aug. 28, 2025 — Enjoy a pint of beer, a glass of wine or a dram of whiskey? Then make sure you have some healthy eats and a good dose of exercise on the side, a...
Vaping Is A Gateway To Smoking, Evidence Says
THURSDAY, Aug. 21, 2025 — Vaping appears to act as a gateway to cigarette smoking among young people, a new evidence review says. E-cigarettes also were significantly...
Fewer Americans Are Drinking Alcohol as Health Concerns Rise
THURSDAY, Aug. 14, 2025 — Fewer U.S. adults say they drink alcohol, and more now believe that even moderate drinking can harm their health, a new Gallup poll finds. The...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.